StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ajit Mishra, Religare

BUYSun Pharmaceutical Industries Ltd.

byAjit Mishra, ReligareHorizon: NA (inferred Swing (≤2wk))15 Jul 2026via ET Now

Entry₹1,953.4Inferred
Target₹2,090
Total upside +6.99% (call closed)
Stop loss₹1,880-3.76% risk
At expiry₹1,99129 Jul 2026, 3:30 pm
Expired+1.92%
Follow Ajit Mishra for new calls(26% target hit, 87 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 126 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Jul 2026
6 supporting3 opposing
Supports the BUY call (6)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·27 Jul · 2d ago

Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.

BSE · Company Update·24 Jul · 5d ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·24 Jul · 5d ago

Sun Pharmaceutical Industries advances Tuesday, outperforms market

NewsGoogle News·21 Jul · 1w ago

(opens in new tab)

Sun Pharmaceutical Industries rises Monday, outperforms competitors

NewsGoogle News·20 Jul · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma slip on Trump's generic drug tariff plan

NewsGoogle News·23 Jul · 6d ago

(opens in new tab)

Indian pharma stocks fall after Trump outlines tariffs on generics

NewsGoogle News·22 Jul · 1w ago

(opens in new tab)

Sun Pharmaceutical Industries falls Friday, outperforms competitors

NewsGoogle News·17 Jul · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.